• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC QDOT-MICRO, BI-DIRECTIONAL, F-J CURVE, C3, SPLIT HANDLE; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC QDOT-MICRO, BI-DIRECTIONAL, F-J CURVE, C3, SPLIT HANDLE; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Catalog Number D139504
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Nerve Damage (1979); Paralysis (1997)
Event Date 09/05/2023
Event Type  Injury  
Manufacturer Narrative
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Event Description
It was reported that a patient underwent an atrial fibrillation ablation procedure using a qdot-micro, bi-directional, f-j curve, c3, split handle (unknown lot).After ablation, the patient experienced phrenic nerve palsy that required prolonged hospitalization.Female patient experienced phrenic nerve palsy and hospitalization for 7 days after a carto af ablation using qdot and octaray catheters.No further information is available at the time of this report.
 
Manufacturer Narrative
On 18-oct-2023, bwi received additional information regarding the event.The physician's opinion on the cause of this adverse event (right phrenic nerve palsy) is rf (radiofrequency) ablation (qdot catheter at 50w) for pulmonary vein isolation.Conservative intervention for the phrenic nerve palsy was provided.Patient has recovered--however, the patient was not fully recovered by discharged date.A reassessment was scheduled to take place a few weeks post discharge.Patient required extended hospitalization for 8 days instead of the originally planned one-day stay.The prolonged stay was for significant respiratory symptoms due to hypoxia from phrenic nerve palsy.Patient had cxr (chest xray) and chest uss (ultrasound scan) confirming right phrenic nerve palsy.As a result, the e0123 (nerve damage) health effect - clinical code in h6 has been removed.And e012202 (paralysis) has been added.Additionally, the device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturer record evaluation cannot be conducted because the no lot number was provided by the customer.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Manufacturer Narrative
Udi : related data quality updates only.Correction to the initial mdr, incomplete udi was provided without an explanation.D4: udi: as the lot number for the device involved in the event was not provided, the full udi is currently not available.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.No: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QDOT-MICRO, BI-DIRECTIONAL, F-J CURVE, C3, SPLIT HANDLE
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key17943264
MDR Text Key325764946
Report Number2029046-2023-02328
Device Sequence Number1
Product Code DRF
UDI-Device Identifier10846835016741
UDI-Public10846835016741
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P210027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 11/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberD139504
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/16/2023
Supplement Dates Manufacturer Received10/18/2023
07/11/2024
Supplement Dates FDA Received11/14/2023
07/19/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CARTO 3 SYSTEM; CARTO VISITAG MODULE; NGEN GENERATOR; OCTARAY CATHETER; THERMOCOOL SMARTTOUCH
Patient Outcome(s) Life Threatening; Hospitalization;
Patient SexFemale
-
-